 Von Samedi
Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pathologists | 1 | 2021 | 15 | 0.750 |
Why?
| | Minority Groups | 1 | 2021 | 232 | 0.650 |
Why?
| | Abdominal Pain | 2 | 2015 | 137 | 0.570 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2017 | 120 | 0.520 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2017 | 187 | 0.500 |
Why?
| | Head and Neck Neoplasms | 3 | 2023 | 425 | 0.480 |
Why?
| | Pancreatitis | 1 | 2015 | 107 | 0.470 |
Why?
| | Endovascular Procedures | 1 | 2017 | 276 | 0.440 |
Why?
| | Celiac Disease | 1 | 2015 | 266 | 0.400 |
Why?
| | Ascites | 2 | 2014 | 35 | 0.390 |
Why?
| | Mesothelioma | 1 | 2010 | 31 | 0.360 |
Why?
| | Peritoneal Neoplasms | 1 | 2010 | 54 | 0.360 |
Why?
| | Down Syndrome | 1 | 2015 | 336 | 0.350 |
Why?
| | Thy-1 Antigens | 2 | 2020 | 11 | 0.340 |
Why?
| | Biopsy | 4 | 2020 | 1056 | 0.330 |
Why?
| | B7-H1 Antigen | 2 | 2020 | 138 | 0.300 |
Why?
| | Crohn Disease | 2 | 2020 | 197 | 0.260 |
Why?
| | Mouth Neoplasms | 1 | 2023 | 70 | 0.220 |
Why?
| | Myeloid-Derived Suppressor Cells | 1 | 2023 | 54 | 0.210 |
Why?
| | Larynx | 1 | 2023 | 48 | 0.210 |
Why?
| | Ascitic Fluid | 2 | 2014 | 15 | 0.210 |
Why?
| | Sentinel Lymph Node | 1 | 2022 | 38 | 0.210 |
Why?
| | Th1 Cells | 2 | 2020 | 125 | 0.190 |
Why?
| | Tonsillar Neoplasms | 1 | 2020 | 7 | 0.190 |
Why?
| | Neoplasms, Unknown Primary | 1 | 2020 | 12 | 0.180 |
Why?
| | Palatine Tonsil | 1 | 2020 | 30 | 0.180 |
Why?
| | Recurrence | 2 | 2015 | 949 | 0.180 |
Why?
| | Gastrointestinal Stromal Tumors | 1 | 2020 | 43 | 0.170 |
Why?
| | Radiosurgery | 1 | 2022 | 298 | 0.170 |
Why?
| | Abscess | 1 | 2020 | 73 | 0.170 |
Why?
| | Papillomavirus Infections | 1 | 2022 | 258 | 0.170 |
Why?
| | Matrix Metalloproteinases | 1 | 2020 | 87 | 0.170 |
Why?
| | Tonsillectomy | 1 | 2020 | 72 | 0.160 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2023 | 577 | 0.160 |
Why?
| | Angiomyolipoma | 1 | 2018 | 18 | 0.160 |
Why?
| | Intestinal Neoplasms | 1 | 2018 | 24 | 0.150 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2023 | 337 | 0.150 |
Why?
| | Stromal Cells | 1 | 2018 | 97 | 0.150 |
Why?
| | Tuberous Sclerosis | 1 | 2018 | 37 | 0.150 |
Why?
| | Stomach Neoplasms | 1 | 2018 | 66 | 0.150 |
Why?
| | Marfan Syndrome | 1 | 2017 | 42 | 0.150 |
Why?
| | Aortography | 1 | 2017 | 51 | 0.150 |
Why?
| | Neuroendocrine Tumors | 1 | 2018 | 83 | 0.140 |
Why?
| | Colitis, Ulcerative | 1 | 2018 | 106 | 0.140 |
Why?
| | Isoflavones | 2 | 2007 | 16 | 0.140 |
Why?
| | Blood Vessel Prosthesis | 1 | 2017 | 117 | 0.140 |
Why?
| | Diagnosis, Differential | 3 | 2015 | 1359 | 0.140 |
Why?
| | Computed Tomography Angiography | 1 | 2017 | 107 | 0.140 |
Why?
| | Cell Membrane | 1 | 2020 | 682 | 0.130 |
Why?
| | Hemochromatosis | 1 | 2015 | 9 | 0.130 |
Why?
| | Acute Disease | 2 | 2015 | 917 | 0.130 |
Why?
| | Duodenoscopy | 1 | 2015 | 7 | 0.130 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 2015 | 70 | 0.130 |
Why?
| | Ferritins | 1 | 2015 | 57 | 0.130 |
Why?
| | Fibroblasts | 1 | 2020 | 838 | 0.130 |
Why?
| | Diet, Gluten-Free | 1 | 2015 | 30 | 0.120 |
Why?
| | Humans | 19 | 2023 | 115908 | 0.120 |
Why?
| | Genistein | 2 | 2006 | 13 | 0.120 |
Why?
| | Kidney Neoplasms | 1 | 2018 | 325 | 0.120 |
Why?
| | Prostatic Neoplasms | 3 | 2007 | 927 | 0.110 |
Why?
| | Stents | 1 | 2017 | 477 | 0.110 |
Why?
| | Antibodies, Neutralizing | 1 | 2015 | 221 | 0.110 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2016 | 352 | 0.110 |
Why?
| | Colonic Neoplasms | 1 | 2015 | 221 | 0.110 |
Why?
| | Gastritis | 1 | 2014 | 84 | 0.110 |
Why?
| | Prednisone | 1 | 2014 | 232 | 0.110 |
Why?
| | Enteritis | 1 | 2014 | 82 | 0.110 |
Why?
| | Extracellular Matrix | 1 | 2016 | 439 | 0.110 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2015 | 389 | 0.110 |
Why?
| | Killer Cells, Natural | 1 | 2015 | 379 | 0.100 |
Why?
| | Hepatitis C | 1 | 2015 | 229 | 0.100 |
Why?
| | Treatment Outcome | 2 | 2017 | 9166 | 0.100 |
Why?
| | Adult | 7 | 2020 | 30820 | 0.100 |
Why?
| | Cholestasis | 1 | 2015 | 225 | 0.100 |
Why?
| | Eosinophilia | 1 | 2014 | 187 | 0.100 |
Why?
| | Macrophages | 2 | 2015 | 1281 | 0.100 |
Why?
| | Pancreatic Neoplasms | 1 | 2018 | 721 | 0.100 |
Why?
| | Patient Compliance | 1 | 2015 | 524 | 0.090 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2007 | 1143 | 0.090 |
Why?
| | Peritoneum | 1 | 2010 | 36 | 0.090 |
Why?
| | Immunohistochemistry | 2 | 2015 | 1643 | 0.090 |
Why?
| | Autopsy | 1 | 2010 | 86 | 0.090 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 1817 | 0.090 |
Why?
| | Fatal Outcome | 1 | 2010 | 286 | 0.090 |
Why?
| | Glucocorticoids | 1 | 2014 | 551 | 0.080 |
Why?
| | Colorectal Neoplasms | 1 | 2015 | 617 | 0.080 |
Why?
| | Neoplasm Metastasis | 1 | 2010 | 526 | 0.080 |
Why?
| | T-Lymphocytes | 1 | 2015 | 1758 | 0.080 |
Why?
| | Male | 9 | 2018 | 56128 | 0.070 |
Why?
| | Soybean Proteins | 1 | 2006 | 10 | 0.070 |
Why?
| | Phytoestrogens | 1 | 2006 | 16 | 0.070 |
Why?
| | Skin | 1 | 2010 | 668 | 0.070 |
Why?
| | Androgens | 1 | 2007 | 165 | 0.060 |
Why?
| | Female | 8 | 2023 | 60086 | 0.060 |
Why?
| | Inflammation | 1 | 2015 | 2503 | 0.060 |
Why?
| | Interleukin-8 | 1 | 2006 | 243 | 0.060 |
Why?
| | Phosphatidylinositol 3-Kinase | 1 | 2023 | 26 | 0.060 |
Why?
| | Phosphatidylinositols | 1 | 2023 | 53 | 0.060 |
Why?
| | Mice | 5 | 2023 | 15075 | 0.060 |
Why?
| | Carcinogens | 1 | 2023 | 105 | 0.050 |
Why?
| | Constriction, Pathologic | 1 | 2023 | 210 | 0.050 |
Why?
| | Steroids | 1 | 2023 | 147 | 0.050 |
Why?
| | Aged | 3 | 2023 | 19299 | 0.050 |
Why?
| | Carcinogenesis | 1 | 2023 | 177 | 0.050 |
Why?
| | Anticarcinogenic Agents | 1 | 2002 | 67 | 0.050 |
Why?
| | Gene Expression | 1 | 2007 | 1442 | 0.050 |
Why?
| | Lymph Node Excision | 1 | 2022 | 140 | 0.050 |
Why?
| | Trachea | 1 | 2023 | 234 | 0.050 |
Why?
| | Tonsillitis | 1 | 2020 | 6 | 0.050 |
Why?
| | Nontuberculous Mycobacteria | 1 | 2023 | 207 | 0.050 |
Why?
| | Neoadjuvant Therapy | 1 | 2022 | 301 | 0.050 |
Why?
| | Unnecessary Procedures | 1 | 2020 | 43 | 0.040 |
Why?
| | Combined Modality Therapy | 1 | 2022 | 1128 | 0.040 |
Why?
| | Th17 Cells | 1 | 2020 | 58 | 0.040 |
Why?
| | Cytokines | 2 | 2018 | 1857 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 3 | 2007 | 754 | 0.040 |
Why?
| | Immunotherapy | 1 | 2022 | 480 | 0.040 |
Why?
| | Animals | 5 | 2023 | 32123 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2018 | 134 | 0.040 |
Why?
| | Microscopy, Confocal | 1 | 2018 | 298 | 0.040 |
Why?
| | Atrial Remodeling | 1 | 2016 | 7 | 0.040 |
Why?
| | Myofibroblasts | 1 | 2018 | 114 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2018 | 2581 | 0.030 |
Why?
| | Immunoblotting | 1 | 2016 | 283 | 0.030 |
Why?
| | Actins | 1 | 2018 | 385 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2015 | 4769 | 0.030 |
Why?
| | Pancreas | 1 | 2018 | 280 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 2016 | 399 | 0.030 |
Why?
| | Phlebotomy | 1 | 2015 | 11 | 0.030 |
Why?
| | Liver Failure | 1 | 2015 | 84 | 0.030 |
Why?
| | Blood Chemical Analysis | 1 | 2015 | 91 | 0.030 |
Why?
| | Biopsy, Needle | 1 | 2015 | 183 | 0.030 |
Why?
| | Chromatography, Liquid | 1 | 2016 | 346 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2018 | 1056 | 0.030 |
Why?
| | Incidence | 1 | 2020 | 2333 | 0.030 |
Why?
| | Ileum | 1 | 2014 | 93 | 0.030 |
Why?
| | Intestinal Mucosa | 1 | 2018 | 528 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2016 | 661 | 0.030 |
Why?
| | Diarrhea | 1 | 2014 | 173 | 0.030 |
Why?
| | Middle Aged | 3 | 2018 | 27084 | 0.030 |
Why?
| | Tumor Cells, Cultured | 2 | 2006 | 850 | 0.030 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2018 | 965 | 0.030 |
Why?
| | Kidney | 1 | 2018 | 1208 | 0.020 |
Why?
| | Proteomics | 1 | 2016 | 855 | 0.020 |
Why?
| | Chronic Pain | 1 | 2014 | 211 | 0.020 |
Why?
| | Laparoscopy | 1 | 2014 | 400 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 2362 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2018 | 2409 | 0.020 |
Why?
| | Biomarkers | 1 | 2018 | 3474 | 0.020 |
Why?
| | Cyclin B | 1 | 2007 | 13 | 0.020 |
Why?
| | Forkhead Box Protein O3 | 1 | 2007 | 13 | 0.020 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2007 | 69 | 0.020 |
Why?
| | Biological Availability | 1 | 2007 | 119 | 0.020 |
Why?
| | Culture Media | 1 | 2007 | 156 | 0.020 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2007 | 107 | 0.020 |
Why?
| | Prostate-Specific Antigen | 1 | 2007 | 152 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2007 | 170 | 0.020 |
Why?
| | Protein Biosynthesis | 1 | 2007 | 389 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2015 | 1842 | 0.020 |
Why?
| | Down-Regulation | 1 | 2007 | 605 | 0.020 |
Why?
| | Cell Cycle | 1 | 2007 | 546 | 0.010 |
Why?
| | Up-Regulation | 1 | 2007 | 824 | 0.010 |
Why?
| | Heart Failure | 1 | 2016 | 1959 | 0.010 |
Why?
| | Young Adult | 1 | 2018 | 10518 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2007 | 1868 | 0.010 |
Why?
| | Transplantation, Heterologous | 1 | 2002 | 188 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2002 | 262 | 0.010 |
Why?
| | Neoplasm Transplantation | 1 | 2002 | 235 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2007 | 1318 | 0.010 |
Why?
| | Mice, Nude | 1 | 2002 | 639 | 0.010 |
Why?
| | Cell Division | 1 | 2002 | 760 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2007 | 1548 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2007 | 2749 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 17955 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2007 | 2196 | 0.010 |
Why?
| | DNA | 1 | 2006 | 1358 | 0.010 |
Why?
| | Cell Cycle Proteins | 1 | 2002 | 555 | 0.010 |
Why?
|
|
Samedi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|